Novel twin study implicates IL-6 in the etiology of young adult Hodgkin lymphoma
Cytokines are small secreted or membranebound proteins that act in both an autocrine and paracrine fashion and have a central role in the development and regulation of the immune system. There is increasing interest in the role of these proteins in cancer etiology and pathogenesis. 1,2 Interleukin 6 (IL-6) is a pro-inflammatory, pleiotropic cytokine produced by multiple cell types, including normal and malignant B and T lymphocytes. 2 Growing laboratory and clinical evidence supports the hypothesis that IL-6 plays a role in the pathogenesis of hematologic and other malignancies. 2, 3 In Hodgkin lymphoma specifically, IL-6 levels are elevated in untreated and relapsed patients and in patients with a poorer prognosis. 3 However, it has not been shown to date whether higher IL-6 levels before diagnosis (and thus unaffected by disease or treatment) are associated with risk of developing Hodgkin lymphoma, which would support an etiologic role for IL-6.
The article by Cozen and colleagues (page 3216) that appears in this issue of Blood addresses the association of IL-6 with the development of young-onset Hodgkin lymphoma (diagnosed under age 50 years) using a novel study design that integrates both genetic and phenotypic data. Using a twin registry, the authors recruited 88 young adult Hodgkin lymphoma patients, their twins, and unrelated age-matched controls, creating triads. Peripheral blood was collected on the same day from each member of the triad, shipped, and processed together. The unaffected twin of monozygotic twin pairs was used as a "surrogate case" whose immune characteristics reflect those of the affected twin, at least to the extent that IL-6 levels are genetically controlled but are not influenced by Hodgkin lymphoma or its treatment. Cozen et al found that unaffected monozygotic twins of the Hodgkin lymphoma cases had IL-6 levels that were approximately 70% greater compared with controls. The IL-6 gene also has a functional single nucleotide polymorphism (SNP) in the promotor region (Ϫ174GϾC), such that the CC genotype is associated with lower levels of IL-6. 3 In their study, affected twins were 70% less likely to have the low-risk (CC) genotype compared with controls, and there was a dose response with the number of low-risk (C) alleles. Finally, among unaffected twins and controls there was an inverse association of IL-6 levels with the number of C alleles, linking phenotype with genotype in this study population.
Taken together, these provocative results support the hypothesis that high levels of genetically determined IL-6 are associated with risk of young adult Hodgkin lymphoma. Is this a causal association? Maybe, but it is too early to make this conclusion. Replication of these findings will be needed. It must also be kept in mind that IL-6 is unlikely to be a lone player, as it is a part 
Unique genetics of human embryonic stem cells
Human embryonic stem (huES) cells have been widely touted as an important source of cells and tissues for future transplantation and regenerative medicine therapies. Since the derivation and propagation of huES cell lines was first described in 1998, 1 several research groups have defined methods to derive and characterize cell lineages of therapeutic interest. These differentiated cell types derived from huES cells include blood cells, endothelial cells, neurons, cardiomyocytes, and bone. Lost in the rush to produce huES cellbased therapies have been efforts to better characterize the basic biology of the undifferentiated ES cells. These unique cells are able to self-renew as undifferentiated cells in culture essentially indefinitely. Yet, when placed in the proper environment, ES cells retain the ability to form any cell type within the body. These dual capacities make ES cells an especially intriguing and informative resource to understand early human embryology. While most developmental biology research uses valuable model organisms such as worms, flies, fish, and mice, we now have the ability to study the very beginning stages of development in a human model system. Indeed, the use of huES cells to characterize the molecular and genetic mechanisms that lead to early cell fate decisions in a human developmental biology system will impact many fields, and the importance of this work will likely supercede therapies directly derived from these cells.
Toward this goal, Bhattacharya and colleagues (page 2956) perform an extensive cDNA microarray analysis of 6 different huES cell lines. There are several important findings in this informative analysis. First, from a genetic standpoint, the 6 ES cell lines are remarkably similar. This was not a foregone conclusion or trivial finding, since these cell lines are obtained from 3 different sources and cultured with subtle differences. Yet 92 of the 98 most highly expressed genes were common to all 6 ES cell lines. Second, there is relatively little similarity between the most highly expressed genes in the huES cells as compared with mouse ES cell lines. Depending on the analysis used for comparison, only 15% to 35% of genes are conserved between ES cells of mouse and man. Similar results are found in other studies. 2, 3 Third, huES cells express many novel genes and hypothetical proteins that remain poorly characterized. Further investigation of these gene products will likely be helpful to gain a better understanding of the self-renewal potential of huES cells and other stem cell populations. Fourth, undifferentiated huES cells express several genes that are typically thought to be lineage specific (eg, skin and cardiac proteins). Therefore, it is crucial that studies that use RT-PCR analysis to demonstrate lineagespecific differentiation also examine the specific genes in the starting population of undifferentiated ES cells. Since huES cells may have low levels of "promiscuous" gene expression, and ES cell cultures may contain some differentiated cells that are not readily apparent, quantitative analysis of gene transcripts is warranted for comparison to differentiated cell populations.
At least 3 other recent reports also characterize gene expression profiles in huES cells. [2] [3] [4] Since each study is done in a different manner, they nicely complement each other. One important conclusion from these and other huES cell-based studies is so obvious it is often overlooked or left unstated-humans are not mice. The time is now right to translate related stem cell research to human models.
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